European Commission authorises remdesivir for Covid-19 treatment

The EU has expedited the authorisation, approving the drug in an exceptionally short timeframe

The European Commission on Friday authorised anti-viral drug remdesivir for treatment against coronavirus, making it the first drug authorised at the European Union-level for the treatment of Covid-19.

"Today, the European Commission granted a conditional marketing authorisation for the medicine remdesivir," the European Commission said in a press release, Xinhua reported.

Stella Kyriakides, Commissioner for Health and Food Safety, said: "Today's authorisation of a first medicine to treat Covid-19 is an important step forward in the fight against this virus... We will leave no stone unturned in our efforts to secure efficient treatments or vaccine against the coronavirus."